drugset / Trial / NCT00205283
Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the impact of prospective drug level monitoring and dose-adjustment of nelfinavir (NFV) on the clinical and virologic outcomes in a group of HIV-infected patients who have achieved virologic success while receiving a nelfinavir containing highly active antiretroviral therapy (HAART) regimen.
Timeline
- Start
- 2003-08
- Primary completion
- 2005-08-01
- Completion
- 2005-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nelfinavir | Other / unclassified | — | — |